Advertisement
Advertisement
U.S. markets close in 2 hours 46 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Acumen Pharmaceuticals, Inc. (ABOS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
6.70+0.13 (+2.05%)
As of 12:59PM EST. Market open.
Advertisement

Acumen Pharmaceuticals, Inc.

427 Park Street
Charlottesville, VA 22902
United States
434 297 1000
https://acumenpharm.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees14

Key Executives

NameTitlePayExercisedYear Born
Mr. Daniel J. O'Connell M.B.A.CEO, Pres & Director801.62kN/A1971
Mr. Matt ZugaCFO, Chief Bus. Officer & Corp. Sec.679.27kN/AN/A
Dr. Eric Siemers M.D.Chief Medical Officer460.64kN/A1955
Mr. Russell Barton M.S.Chief Operating OfficerN/AN/A1959
Mr. Derek M. Meisner Esq., J.D.Chief Legal OfficerN/AN/A1971
Ms. Robyn Moxon M.A.Mang. of Corp. & Clinical CommunicationsN/AN/AN/A
Ms. Julie BockenstetteExec. VP & Head of HRN/AN/AN/A
Ms. Siew Tin Gan M.S.Assistant VP & Head of Clinical OperationsN/AN/AN/A
Ms. Janice HitchcockVP & Head of Regulatory AffairsN/AN/AN/A
Ms. Liean Schenck M.S.VP & Head of CMCN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

Corporate Governance

Acumen Pharmaceuticals, Inc.’s ISS Governance QualityScore as of January 28, 2023 is 7. The pillar scores are Audit: 8; Board: 6; Shareholder Rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement